Back
ESC2025 Premium Access

Progressive disease substrate in obese type 2 diabetic patients with coronary artery disease despite achieving HbA1c <7.0%: sub-analysis from the OPTIMAL randomized study

Session: Diabetes and the heart (3)
Topic: Pathophysiology
Speaker: Doctor A. Salib (Melbourne, AU)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Anthony Salib

Austin Hospital, Melbourne (Australia)
1 follower

4 more presentations in this session

GLP-1 receptor agonists and SGLT2-inhibitors in patients with diabetes and ischaemic heart disease in primary care

Speaker: Doctor T. Andersson (Gothenburg, SE)

Access
Abstract
Slides
Video
Like
Thumbnail

Use of cardioprotective glucose lowering therapy before and after myocardial infarction among patients with type-2 diabetes: a nationwide registry study

Speaker: Ms B. Sharad (Malmo, SE)

Access
Abstract
Slides
Video
Like
Thumbnail

Tirzepatide and the risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials

Speaker: Doctor E. Mansouri (Tehran, IR) Mr L. Barbosa (Belo Horizonte, BR)

Access
Abstract
Slides
Video
Like
Thumbnail

The impact of age of onset and duration of Type 2 diabetes on life expectancy and serious health outcomes

Speaker: Doctor J. Isufi (Gothenburg, SE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Diabetes and the heart (3)

Speakers: Doctor A. Salib, Doctor T. Andersson, Ms B. Sharad, Doctor E. Mansouri, Mr L. Barbosa...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources